{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,8]],"date-time":"2026-07-08T02:18:31Z","timestamp":1783477111551,"version":"3.55.0"},"reference-count":60,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2024,11,25]],"date-time":"2024-11-25T00:00:00Z","timestamp":1732492800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Immunol."],"abstract":"<jats:sec><jats:title>Introduction<\/jats:title><jats:p>Dermatomyositis (DM) is an idiopathic inflammatory myopathy. Because of clinical heterogeneity, the metabolite profile of DM patients with different myositis-specific autoantibodies (MSAs) remains elusive. This study aimed to explore the metabolomics characteristics of the serum in DM with different MSAs, low or high disease activity, and interstitial lung disease.<\/jats:p><\/jats:sec><jats:sec><jats:title>Methods<\/jats:title><jats:p>Untargeted metabolomics profiling was performed in the serum of a discovery cohort (n=96) and a validation cohort (n=40), consisting of DM patients with MSAs, low or high disease activity, and\/or interstitial lung disease (DM-ILD) compared to age- and gender-matched healthy controls (HCs).<\/jats:p><\/jats:sec><jats:sec><jats:title>Results<\/jats:title><jats:p>The lipid profile in DM was found to be abnormal, especially dysregulated glycerophospholipid metabolism and fatty acid oxidation, which might affect the pathogenesis of DM by disrupting the balance of Th17 and Treg. We identified potential biomarkers of DM that can distinguish between low or high disease activity and reflect lung involvement. Two metabolite combinations including pro-leu, FA 14:0;O can distinguish high disease activity DM from low disease activity DM and HCs, and five including indole-3-lactic acid, dihydrosphingosine, SM 32:1;O2, NAE 17:1, and cholic acid can distinguish DM-ILD from DM without ILD (DM-nonILD). DM with different MSAs had unique metabolic characteristics, which can distinguish between MDA5+DM, Jo-1+DM, and TIF1-\u03b3+DM, and from the antibody-negative groups. The sphingosine metabolism has been found to play an important role in MDA5+DM, which was associated with the occurrence of ILD.<\/jats:p><\/jats:sec><jats:sec><jats:title>Discussion<\/jats:title><jats:p>Altered metabolic profiles of dermatomyositis were associated with different myositisspecific autoantibodies, disease activity, and interstitial lung disease, which can help in the early diagnosis, prognosis, or selection of new therapeutic targets for DM.<\/jats:p><\/jats:sec>","DOI":"10.3389\/fimmu.2024.1429010","type":"journal-article","created":{"date-parts":[[2024,11,25]],"date-time":"2024-11-25T06:25:33Z","timestamp":1732515933000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":7,"title":["Altered metabolic profiles of dermatomyositis with different myositis-specific autoantibodies associated with clinical phenotype"],"prefix":"10.3389","volume":"15","author":[{"given":"Nan","family":"Wang","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lili","family":"Shang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhaojun","family":"Liang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Min","family":"Feng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yanlin","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chong","family":"Gao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jing","family":"Luo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1965","published-online":{"date-parts":[[2024,11,25]]},"reference":[{"key":"B1","doi-asserted-by":"publisher","DOI":"10.1016\/j.jaad.2019.06.1309","article-title":"Dermatomyositis: Clinical features and pathogenesis","volume":"82","author":"DeWane","year":"2020","journal-title":"J Am Acad Dermatol"},{"key":"B2","doi-asserted-by":"publisher","first-page":"151959","DOI":"10.1016\/j.semarthrit.2022.151959","article-title":"Management of MDA-5 antibody positive clinically amyopathic dermatomyositis associated interstitial lung disease: A systematic review","volume":"53","author":"McPherson","year":"2022","journal-title":"Semin Arthritis Rheum"},{"key":"B3","doi-asserted-by":"publisher","first-page":"347","DOI":"10.3390\/medicina57040347","article-title":"Management of myositis-associated interstitial lung disease","volume":"57","author":"Fujisawa","year":"2021","journal-title":"Medicina"},{"key":"B4","doi-asserted-by":"publisher","DOI":"10.1016\/j.semarthrit.2020.11.009","article-title":"Prevalence of interstitial lung disease in polymyositis and dermatomyositis: A meta-analysis from 2000 to 2020","volume":"51","author":"Sun","year":"2021","journal-title":"Semin Arthritis Rheum"},{"key":"B5","doi-asserted-by":"publisher","DOI":"10.1002\/art.42308","article-title":"Identification of three different phenotypes in anti-MDA5 antibody-positive dermatomyositis patients: implications for rapidly progressive interstitial lung disease prediction","volume":"75","author":"Xu","year":"2022","journal-title":"Arthritis Rheumatol"},{"key":"B6","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1080\/1744666X.2023.2270737","article-title":"A comprehensive review of dermatomyositis treatments - from rediscovered classics to promising horizons","volume":"16","author":"Sevim","year":"2023","journal-title":"Expert Rev Clin Immunol"},{"key":"B7","doi-asserted-by":"publisher","first-page":"290","DOI":"10.1038\/nrrheum.2018.56","article-title":"Autoantibodies in myositis","volume":"14","author":"McHugh","year":"2018","journal-title":"Nat Rev Rheumatol"},{"key":"B8","doi-asserted-by":"publisher","first-page":"12","DOI":"10.1186\/s42358-021-00171-x","article-title":"The relevance of anti-Jo-1 autoantibodies in patients with definite dermatomyositis","volume":"61","author":"de Andrade","year":"2021","journal-title":"Adv Rheumatol"},{"key":"B9","doi-asserted-by":"publisher","first-page":"18","DOI":"10.1051\/medsci\/2019178","article-title":"Dermatomyositis: new antibody, new classification","author":"Bolko","year":"2019","journal-title":"Med Sci (Paris)"},{"key":"B10","doi-asserted-by":"publisher","first-page":"293","DOI":"10.1007\/s12016-020-08822-5","article-title":"Interstitial lung disease in anti-MDA5 positive dermatomyositis","volume":"60","author":"Wu","year":"2021","journal-title":"Clin Rev Allergy Immunol"},{"key":"B11","doi-asserted-by":"publisher","first-page":"435","DOI":"10.21037\/atm-20-5319","article-title":"Polishing the crystal ball: mining multi-omics data in dermatomyositis","volume":"9","author":"Castillo","year":"2021","journal-title":"Ann Transl Med"},{"key":"B12","doi-asserted-by":"publisher","DOI":"10.1016\/j.autrev.2017.07.021","article-title":"Using multi-omics methods to understand dermatomyositis\/polymyositis","volume":"16","author":"Gao","year":"2017","journal-title":"Autoimmun Rev"},{"key":"B13","doi-asserted-by":"publisher","first-page":"77","DOI":"10.1007\/s11306-019-1539-9","article-title":"Metabolomic profiling for identification of potential biomarkers in patients with dermatomyositis","volume":"15","author":"Zhang","year":"2019","journal-title":"Metabolomics"},{"key":"B14","doi-asserted-by":"publisher","first-page":"83","DOI":"10.1186\/s13075-018-1579-y","article-title":"Targeted lipidomics analysis identified altered serum lipid profiles in patients with polymyositis and dermatomyositis","volume":"20","author":"Raouf","year":"2018","journal-title":"Arthritis Res Ther"},{"key":"B15","doi-asserted-by":"publisher","DOI":"10.1093\/rheumatology\/keab520","article-title":"Metabolomics analysis identifies a lipidomic profile in treatment-na\u00efve juvenile dermatomyositis patients vs healthy control subjects","volume":"61","author":"Dvergsten","year":"2022","journal-title":"Rheumatology"},{"key":"B16","doi-asserted-by":"publisher","first-page":"105912","DOI":"10.1016\/j.intimp.2019.105912","article-title":"Absolute reduction of regulatory T cells and regulatory effect of short-term and low-dose IL-2 in polymyositis or dermatomyositis","volume":"77","author":"Feng","year":"2019","journal-title":"Int Immunopharmacol"},{"key":"B17","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2021.773352","article-title":"Dermatomyositis with anti-MDA5 antibodies: Bioclinical features, pathogenesis and emerging therapies","volume":"12","author":"Nombel","year":"2021","journal-title":"Front Immunol"},{"key":"B18","doi-asserted-by":"publisher","first-page":"103464","DOI":"10.1016\/j.autrev.2023.103464","article-title":"Clinical features of dermatomyositis patients with anti-TIF1 antibodies: A case based comprehensive review","volume":"22","author":"Kilinc","year":"2023","journal-title":"Autoimmun Rev"},{"key":"B19","doi-asserted-by":"publisher","DOI":"10.1111\/1346-8138.15284","article-title":"Clinical significance of serum levels of anti-transcriptional intermediary factor 1-\u03b3 antibody in patients with dermatomyositis","volume":"47","author":"Ikeda","year":"2020","journal-title":"J Dermatol"},{"key":"B20","doi-asserted-by":"publisher","DOI":"10.2147\/IJGM.S315885","article-title":"Clinical characteristics of lipid metabolism in untreated patients with anti-MDA5 antibody-positive","volume":"14","author":"Huang","year":"2021","journal-title":"Int J Gen Med"},{"key":"B21","doi-asserted-by":"publisher","DOI":"10.1016\/j.plipres.2020.101068","article-title":"Emerging roles of lysophospholipids in health and disease","volume":"80","author":"Tan","year":"2020","journal-title":"Prog Lipid Res"},{"key":"B22","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1093\/gigascience\/gix087","article-title":"Lipidomics profiling reveals the role of glycerophospholipid metabolism in psoriasis","volume":"6","author":"Zeng","year":"2017","journal-title":"GigaScience"},{"key":"B23","doi-asserted-by":"publisher","DOI":"10.1039\/C8AN01046C","article-title":"Lipid metabolism in inflammation-related diseases","volume":"143","author":"Zhang","year":"2018","journal-title":"Analyst"},{"key":"B24","doi-asserted-by":"publisher","DOI":"10.1172\/JCI97944","article-title":"Phospholipid signaling in innate immune cells","volume":"128","author":"O'Donnell","year":"2018","journal-title":"J Clin Invest"},{"key":"B25","doi-asserted-by":"publisher","first-page":"28","DOI":"10.1186\/s12964-021-00715-0","article-title":"Phosphoinositides signaling modulates microglial actin remodeling and phagocytosis in Alzheimer\u2019s disease","volume":"19","author":"Desale","year":"2021","journal-title":"Cell Commun Signal"},{"key":"B26","doi-asserted-by":"publisher","first-page":"295","DOI":"10.1038\/nrrheum.2014.2","article-title":"The skeletal muscle arachidonic acid cascade in health and inflammatory disease","volume":"10","author":"Korotkova","year":"2014","journal-title":"Nat Rev Rheumatol"},{"key":"B27","doi-asserted-by":"publisher","first-page":"3683","DOI":"10.3390\/ijms20153683","article-title":"Arachidonic acid metabolism and kidney inflammation","volume":"20","author":"Wang","year":"2019","journal-title":"Int J Mol Sci"},{"key":"B28","doi-asserted-by":"publisher","first-page":"114953","DOI":"10.1016\/j.bcp.2022.114953","article-title":"Oxidized linoleic acid metabolites maintain mechanical and thermal hypersensitivity during sub-chronic inflammatory pain","volume":"198","author":"Wedel","year":"2022","journal-title":"Biochem Pharmacol"},{"key":"B29","doi-asserted-by":"publisher","DOI":"10.1016\/j.plefa.2018.03.004","article-title":"Omega-6 fatty acids and inflammation","volume":"132","author":"Innes","year":"2018","journal-title":"Prostaglandins Leukot Essent Fatty Acids"},{"key":"B30","doi-asserted-by":"publisher","first-page":"108484","DOI":"10.1016\/j.jnutbio.2020.108484","article-title":"Cytochrome P450-derived linoleic acid metabolites EpOMEs and DiHOMEs: a review of recent studies","volume":"86","author":"Hildreth","year":"2020","journal-title":"J Nutr Biochem"},{"key":"B31","doi-asserted-by":"publisher","DOI":"10.1097\/BOR.0000000000000413","article-title":"Metabolic abnormalities and oxidative stress in lupus","volume":"29","author":"Lightfoot","year":"2017","journal-title":"Curr Opin Rheumatol"},{"key":"B32","doi-asserted-by":"publisher","first-page":"591","DOI":"10.1016\/j.cmet.2020.07.001","article-title":"Mitochondrial oxidative damage underlies regulatory T cell defects in autoimmunity","volume":"32","author":"Alissafi","year":"2020","journal-title":"Cell Metab"},{"key":"B33","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2021.703972","article-title":"Targeting mitochondrial-derived reactive oxygen species in T cell-mediated autoimmune diseases","volume":"12","author":"Ch\u00e1vez","year":"2021","journal-title":"Front Immunol"},{"key":"B34","doi-asserted-by":"publisher","first-page":"2526174","DOI":"10.1155\/2016\/2526174","article-title":"Oxidative stress and Treg and Th17 dysfunction in systemic lupus erythematosus","volume":"2016","author":"Yang","year":"2016","journal-title":"Oxid Med Cell Longev"},{"key":"B35","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.plipres.2018.08.001","article-title":"Lipid storage myopathies: Current treatments and future directions","volume":"72","author":"Vasiljevski","year":"2018","journal-title":"Prog Lipid Res"},{"key":"B36","doi-asserted-by":"publisher","first-page":"451","DOI":"10.3390\/metabo13030451","article-title":"2 hydroxybutyric acid-producing bacteria in gut microbiome and Fusobacterium nucleatum regulates 2 hydroxybutyric acid level in vivo","volume":"13","author":"Qin","year":"2023","journal-title":"Metabolites"},{"key":"B37","doi-asserted-by":"publisher","first-page":"19","DOI":"10.1007\/s13539-012-0079-1","article-title":"Serum creatinine as a marker of muscle mass in chronic kidney disease: results of a cross-sectional study and review of literature","volume":"4","author":"Patel","year":"2013","journal-title":"J Cachexia Sarcopenia Muscle"},{"key":"B38","doi-asserted-by":"publisher","DOI":"10.1152\/physrev.2000.80.3.1107","article-title":"Creatine and creatinine metabolism","volume":"80","author":"Wyss","year":"2000","journal-title":"Physiol Rev"},{"key":"B39","doi-asserted-by":"publisher","first-page":"447","DOI":"10.3390\/nu13020447","article-title":"Creatine in health and disease","volume":"13","author":"Kreider","year":"2021","journal-title":"Nutrients"},{"key":"B40","doi-asserted-by":"publisher","DOI":"10.1111\/resp.13530","article-title":"Metabolomics in chronic lung diseases","volume":"25","author":"Nambiar","year":"2020","journal-title":"Respirology"},{"key":"B41","doi-asserted-by":"publisher","first-page":"1177271919870472","DOI":"10.1177\/1177271919870472","article-title":"Serum metabolomic profiles of rheumatoid arthritis patients with acute-onset diffuse interstitial lung disease","volume":"14","author":"Furukawa","year":"2019","journal-title":"biomark Insights"},{"key":"B42","doi-asserted-by":"publisher","first-page":"357","DOI":"10.1186\/s12866-020-02023-y","article-title":"Indole-3-lactic acid associated with Bifidobacterium-dominated microbiota significantly decreases inflammation in intestinal epithelial cells","volume":"20","author":"Ehrlich","year":"2020","journal-title":"BMC Microbiol"},{"key":"B43","doi-asserted-by":"publisher","DOI":"10.1038\/s41390-019-0740-x","article-title":"Indole-3-lactic acid, a metabolite of tryptophan, secreted by Bifidobacterium longum subspecies infantis is anti-inflammatory in the immature intestine","volume":"88","author":"Meng","year":"2020","journal-title":"Pediatr Res"},{"key":"B44","doi-asserted-by":"publisher","first-page":"13520","DOI":"10.3390\/ijms232113520","article-title":"Effects of indole-3-lactic acid, a metabolite of tryptophan, on IL-4 and IL-13-induced human skin-equivalent atopic dermatitis models","volume":"23","author":"Kim","year":"2022","journal-title":"Int J Mol Sci"},{"key":"B45","doi-asserted-by":"publisher","first-page":"264","DOI":"10.1186\/s12967-023-04109-3","article-title":"Microbiota-derived tryptophan metabolites indole-3-lactic acid is associated with intestinal ischemia\/reperfusion injury via positive regulation of YAP and Nrf2","volume":"21","author":"Zhang","year":"2023","journal-title":"J Transl Med"},{"key":"B46","doi-asserted-by":"publisher","DOI":"10.1038\/s41385-019-0160-6","article-title":"Microbes, metabolites, and the gut-lung axis","volume":"12","author":"Dang","year":"2019","journal-title":"Mucosal Immunol"},{"key":"B47","doi-asserted-by":"publisher","first-page":"118616","DOI":"10.1016\/j.lfs.2020.118616","article-title":"Pulmonary fibrosis alters gut microbiota and associated metabolites in mice: An integrated 16S and metabolomics analysis","volume":"264","author":"Gong","year":"2021","journal-title":"Life Sci"},{"key":"B48","doi-asserted-by":"publisher","first-page":"113810","DOI":"10.1016\/j.biopha.2022.113810","article-title":"Gut microbiota: A new insight into lung\u00a0diseases","volume":"155","author":"Ma","year":"2022","journal-title":"BioMed Pharmacother"},{"key":"B49","doi-asserted-by":"publisher","first-page":"1958","DOI":"10.3390\/ijms21061958","article-title":"Altered levels of sphingosine, sphinganine and their ceramides in atopic dermatitis are related to skin barrier function, disease severity and local cytokine Milieu","volume":"21","author":"Toncic","year":"2020","journal-title":"Int J Mol Sci"},{"key":"B50","doi-asserted-by":"publisher","DOI":"10.1007\/s00018-018-2984-8","article-title":"The role of dihydrosphingolipids in disease","volume":"76","author":"Magaye","year":"2019","journal-title":"Cell Mol Life Sci"},{"key":"B51","doi-asserted-by":"publisher","first-page":"109629","DOI":"10.1016\/j.cellsig.2020.109629","article-title":"Exogenous dihydrosphingosine 1 phosphate mediates collagen synthesis in cardiac fibroblasts through JAK\/STAT signalling and regulation of TIMP1","volume":"72","author":"Magaye","year":"2020","journal-title":"Cell Signal"},{"key":"B52","doi-asserted-by":"publisher","DOI":"10.1128\/spectrum.00002-22","article-title":"Characterization of a bacterial kinase that phosphorylates dihydrosphingosine to form dhS1P","volume":"10","author":"Ranjit","year":"2022","journal-title":"Microbiol Spectr"},{"key":"B53","doi-asserted-by":"publisher","first-page":"11336","DOI":"10.3390\/ijms241411336","article-title":"The interplay between bioactive sphingolipids in the psoriatic skin and the severity of the disease","volume":"24","author":"Matwiejuk","year":"2023","journal-title":"Int J Mol Sci"},{"key":"B54","doi-asserted-by":"publisher","first-page":"105952","DOI":"10.1016\/j.biocel.2021.105952","article-title":"Attenuating PI3K\/Akt- mTOR pathway reduces dihydrosphingosine 1 phosphate mediated collagen synthesis and hypertrophy in primary cardiac cells","volume":"134","author":"Magaye","year":"2021","journal-title":"Int J Biochem Cell Biol"},{"key":"B55","doi-asserted-by":"publisher","DOI":"10.1038\/s41580-020-0227-y","article-title":"Cellular adaptation to hypoxia through hypoxia inducible factors and beyond","volume":"21","author":"Lee","year":"2020","journal-title":"Nat Rev Mol Cell Bio"},{"key":"B56","doi-asserted-by":"publisher","DOI":"10.1016\/j.cmet.2009.05.005","article-title":"Activation of a HIF1\u03b1-PPAR\u03b3 axis underlies the integration of glycolytic and lipid anabolic pathways in pathologic cardiac hypertrophy","volume":"9","author":"Krishnan","year":"2009","journal-title":"Cell Metab"},{"key":"B57","doi-asserted-by":"publisher","first-page":"1769","DOI":"10.1038\/s41467-017-01965-8","article-title":"HIF drives lipid deposition and cancer in ccRCC via repression of fatty acid metabolism","volume":"8","author":"Du","year":"2017","journal-title":"Nat Commun"},{"key":"B58","doi-asserted-by":"publisher","first-page":"638","DOI":"10.1038\/s42003-020-01367-5","article-title":"Fatty-acid-induced FABP5\/HIF-1 reprograms lipid metabolism and enhances the proliferation of liver cancer cells","volume":"3","author":"Seo","year":"2020","journal-title":"Commun Biol"},{"key":"B59","doi-asserted-by":"publisher","DOI":"10.1093\/jleuko\/qiae126","article-title":"Cellular metabolism and hypoxia interfacing with allergic diseases","volume":"116","author":"Kellett","year":"2024","journal-title":"J Leukoc Biol"},{"key":"B60","doi-asserted-by":"publisher","DOI":"10.1007\/s00018-015-2070-4","article-title":"Reprogramming of glucose, fatty acid and amino acid metabolism for cancer progression","volume":"73","author":"Li","year":"2016","journal-title":"Cell Mol Life Sci"}],"container-title":["Frontiers in Immunology"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fimmu.2024.1429010\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,11,25]],"date-time":"2024-11-25T06:25:35Z","timestamp":1732515935000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fimmu.2024.1429010\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,11,25]]},"references-count":60,"alternative-id":["10.3389\/fimmu.2024.1429010"],"URL":"https:\/\/doi.org\/10.3389\/fimmu.2024.1429010","relation":{},"ISSN":["1664-3224"],"issn-type":[{"value":"1664-3224","type":"electronic"}],"subject":[],"published":{"date-parts":[[2024,11,25]]},"article-number":"1429010"}}